retatrutide clinical trials weight loss results ⭐️topline from TRIUMPH-1, a Phase 3 trial evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with obesity or “overweight” Retatrutide Dosing: Weekly Injections, Clinical
Pay in 4 interest-free payments of $5.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10



















